PerpEquities

Takeda Pharmaceutical Company Limited (TAKEDA) balance sheet

JPX · Healthcare · Drug Manufacturers - Specialty & Generic · 47,029 employees · CEO Julie So-Young Kim

Price
¥6,651.00 +2.78%
Market cap
¥10.6T
Enterprise value
¥14.8T
Last report
Q2 '26 filed 2026-09-30
Next report
2027-01-28 EPS est. ¥88.42

At the end of Q2 '26 Takeda Pharmaceutical Company Limited (TAKEDA) held ¥454B in cash and short-term investments against ¥4.58T of debt incl. leases. Total assets ¥15.3T, total liabilities ¥7.85T, shareholders' equity ¥7.42T.

Balance sheet

Balance sheetTrendQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Assets
Cash & equivalents¥288B¥205B¥804B¥859B¥494B¥234B¥350B¥681B¥655B¥595B¥461B¥419B
Short-term investments¥0¥253B¥0¥0¥0¥151B¥0¥58.2B¥107B¥0¥66.6B¥35.9B
Receivables¥743B¥698B¥772B¥721B¥735B¥725B¥680B¥702B¥758B¥876B¥956B¥910B
Inventory¥1.17T¥1.21T¥1.28T¥1.21T¥1.25T¥1.22T¥1.24T¥1.3T¥1.41T¥1.4T¥1.45T¥1.44T
Other current assets¥228B¥193B¥254B¥268B¥279B¥193B¥243B¥179B¥189B¥222B¥219B¥191B
Current assets¥2.43T¥2.56T¥3.11T¥3.05T¥2.75T¥2.52T¥2.51T¥2.92T¥3.12T¥3.09T¥3.15T¥3T
Property, plant & equipment (net)¥1.84T¥1.99T¥2.09T¥1.89T¥2.02T¥1.97T¥1.96T¥1.98T¥2.08T¥2.12T¥2.14T¥2.28T
Long-term investments¥373B¥431B¥447B¥277B¥410B¥362B¥347B¥374B¥434B¥449B¥473B¥408B
Goodwill¥5.11T¥5.41T¥5.73T¥5.16T¥5.52T¥5.32T¥5.3T¥5.43T¥5.75T¥5.81T¥5.89T¥5.68T
Intangible assets¥4.1T¥4.27T¥4.37T¥3.77T¥3.95T¥3.63T¥3.42T¥3.3T¥3.52T¥3.42T¥3.39T¥3.22T
Deferred tax assets¥317B¥394B¥382B¥338B¥376B¥371B¥401B¥390B¥427B¥488B¥539B¥608B
Other non-current assets¥54.7B¥51.2B¥106B¥85B¥74.2B¥70.3B¥68.6B¥70.5B¥77.8B¥77B¥80.3B¥74.1B
Non-current assets¥11.8T¥12.6T¥13.1T¥11.5T¥12.4T¥11.7T¥11.5T¥11.5T¥12.3T¥12.4T¥12.5T¥12.3T
Total assets¥14.2T¥15.1T¥16.2T¥14.6T¥15.1T¥14.2T¥14T¥14.5T¥15.4T¥15.5T¥15.7T¥15.3T
Liabilities
Accounts payable¥484B¥320B¥469B¥413B¥460B¥476B¥421B¥439B¥468B¥491B¥447B¥486B
Short-term debt¥370B¥433B¥439B¥624B¥135B¥613B¥371B¥294B¥583B¥512B¥520B¥401B
Taxes payable¥112B¥110B¥162B¥141B¥159B¥0¥151B¥123B¥148B¥0¥118B¥117B
Other current liabilities¥1.32T¥1.45T¥1.4T¥1.21T¥1.34T¥1.28T¥1.23T¥1.28T¥1.41T¥1.33T¥1.68T¥1.6T
Current liabilities¥2.28T¥2.31T¥2.47T¥2.39T¥2.1T¥2.51T¥2.17T¥2.14T¥2.61T¥2.43T¥2.76T¥2.6T
Long-term debt¥4.29T¥4.48T¥5.04T¥4.43T¥4.7T¥3.97T¥4.13T¥4.35T¥4.27T¥4.37T¥4.42T¥4.17T
Lease obligations (non-current)¥0¥553B¥0¥0¥0¥509B¥0¥0¥0¥0¥0¥0
Deferred tax liabilities¥133B¥114B¥55.5B¥46.6B¥37.7B¥35.2B¥33.5B¥33B¥31.3B¥26.8B¥27B¥24.3B
Other non-current liabilities¥771B¥378B¥865B¥790B¥847B¥295B¥800B¥814B¥853B¥852B¥893B¥1.05T
Non-current liabilities¥5.2T¥5.52T¥5.96T¥5.26T¥5.59T¥4.81T¥4.97T¥5.2T¥5.15T¥5.25T¥5.34T¥5.25T
Total liabilities¥7.48T¥7.83T¥8.43T¥7.65T¥7.69T¥7.31T¥7.14T¥7.34T¥7.76T¥7.68T¥8.1T¥7.85T
Equity
Common stock & paid-in capital¥1.68T¥1.68T¥1.68T¥1.69T¥1.69T¥1.69T¥1.69T¥1.69T¥1.69T¥1.7T¥1.7T¥1.72T
Retained earnings¥1.4T¥1.39T¥1.34T¥1.43T¥1.29T¥1.19T¥1.16T¥1.15T¥1.1T¥1.06T¥667B¥859B
Accumulated other comprehensive income¥1.99T¥2.51T¥3.07T¥2.08T¥2.7T¥2.35T¥2.35T-¥3.6B¥3.15T¥3.29T-¥11.1B-¥3.22B
Shareholders' equity¥6.74T¥7.27T¥7.8T¥6.92T¥7.42T¥6.94T¥6.87T¥7.13T¥7.64T¥7.77T¥7.56T¥7.42T
Debt
Total debt (incl. leases)¥4.66T¥5.46T¥5.48T¥5.05T¥4.84T¥5.09T¥4.51T¥4.65T¥4.85T¥4.88T¥4.94T¥4.58T
Net debt (debt - cash)¥4.38T¥5.26T¥4.68T¥4.19T¥4.35T¥4.85T¥4.16T¥3.96T¥4.2T¥4.29T¥4.48T¥4.16T

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in JPY.

Cash, investments and debt

quarter ends

The other statements

Income statementRevenue, costs, operating income, net income and EPSOpenCash flowOperating cash flow, capex, free cash flow, buybacks and dividendsOpen

Sources

Statements, segment revenue, metrics and estimates: Financial Modeling Prep.

Data as of 2026-11-01